Iván Oseguera-López

Dr. Iván Oseguera-López

Universidad Autónoma Metropolitana-Iztapalapa
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2019 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
IOIván Oseguera-López
Iván Oseguera-López
SRSara Ruiz-Díaz
Sara Ruiz-Díaz
PIPriscila Ramos Ibeas
Priscila Ramos Ibeas
SPSerafin Perez-Cerezales
Serafin Perez-Cerezales
Almost 50% of the infertility cases are due to male factors. Assisted reproductive technologies (ARTs) allow to overcome the incapacity of these patients’ spermatozoa to fertilize the oocyte and produce a viable and healthy offspring, but the efficiency of the different techniques has still the potential to improve. According to the latest reports of the European Society of Human Reproduction and Embryology (ESHRE) and the Centers for Disease Control and Prevention of the United States (CDC), the percentages of deliveries per ART cycle in 2014 and 2016 were 21 and 22%, respectively. Among the reasons for this relatively low efficiency, the quality of the spermatozoa has been pointed out as critical, and the presence of high percentages of DNA-damaged spermatozoa in patients’ ejaculates is possibly one of the main factors reducing the ARTs outcomes. Thus, one of the main challenges in reproductive medicine is to ensure the highest quality of the spermatozoa used in ARTs, and specifically, in terms of genetic integrity. The latest techniques for the preparation and selection of human spermatozoa are herein discussed focusing on those proven to improve one or several of the following parameters: sperm genetic integrity, fertilization capacity, embryo production, and in vitro survival, as well as pregnancy and delivery rates following in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). In addition, we discuss the potential of techniques developed in non-human mammals that could be further transferred to the clinic.

21 October 2020 in Animals
Verified
Journal Article
Open access
PDF file
IOIván Oseguera-López
Iván Oseguera-López
SPSerafin Perez-Cerezales
Serafin Perez-Cerezales
Paola Ortiz SánchezPaola Ortiz Sánchez
Paola Ortiz Sánchez
OMOscar Mondragon-Payne
Oscar Mondragon-Payne
RSRaúl Sanchez Sanchez
Raúl Sanchez Sanchez
HGHumberto Gonzalez-Marquez
Humberto Gonzalez-Marquez
Perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) are toxic and bioaccumulative, included in the Stockholm Convention’s list as persistent organic pollutants. Due to their toxicity, worldwide distribution, and lack of information in spermatozoa physiology during pre-fertilization processes, the present study seeks to analyze the toxic effects and possible alterations caused by the presence of these compounds in boar sperm during the in vitro capacitation. The spermatozoa capacitation was performed in supplemented TALP-Hepes media and mean lethal concentration values of 460.55 μM for PFOS, and 1930.60 μM for PFHxS were obtained. Results by chlortetracycline staining showed that intracellular Ca2+ patterns bound to membrane proteins were scarcely affected by PFOS. The spontaneous acrosome reaction determined by FITC-PNA was significantly reduced by PFOS and slightly increased by PFHxS. Both toxic compounds significantly alter the normal capacitation process from 30 min of exposure. An increase in ROS production was observed by flow cytometry and considerable DNA fragmentation by the comet assay. The immunocytochemistry showed a decrease of tyrosine phosphorylation in proteins of the equatorial and acrosomal zone of the spermatozoa head. In conclusion, PFOS and PFHxS have toxic effects on the sperm, causing mortality and altering vital parameters for proper sperm capacitation.

29 March 2022 in Reproductive Toxicology
Verified
Journal Article
Closed access
Paola Ortiz SánchezPaola Ortiz Sánchez
Paola Ortiz Sánchez
ARAna L. Roa-Espitia
Ana L. Roa-Espitia
RFReyna Fierro
Reyna Fierro
ALAideé S. López-Torres
Aideé S. López-Torres
IJIrma Jiménez-Morales
Irma Jiménez-Morales
HGHumberto Gonzalez-Marquez
Humberto Gonzalez-Marquez

21 August 2020 in Animals
Verified
Journal Article
Open access
PDF file
SDSara Ruiz Díaz
Sara Ruiz Díaz
IOIván Oseguera-López
Iván Oseguera-López
David De La CuestaDavid De La Cuesta
David De La Cuesta
BGBelén García-López
Belén García-López
CSConsuelo Serres
Consuelo Serres
SPSerafin Perez-Cerezales
Serafin Perez-Cerezales
Assisted reproductive technologies (ARTs) in the horse still yield suboptimal results in terms of pregnancy rates. One of the reasons for this is the lack of optimal conditions for the sperm capacitation in vitro. This study assesses the use of synthetic human tubal fluid (HTF) supplemented with D-penicillamine (HTF + PEN) for the in vitro capacitation of frozen/thawed stallion spermatozoa by examining capacitation-related events over 180 min of incubation. Besides these events, we explored the in vitro capacity of the spermatozoa to migrate by thermotaxis and give rise to a population of high-quality spermatozoa. We found that HTF induced higher levels of hyperactive-like motility and protein tyrosine phosphorylation (PTP) compared to the use of a medium commonly used in this species (Whitten’s). Also, HTF + PEN was able to maintain this hyperactive-like motility, otherwise lost in the absence of PEN, for 180 min, and also allowed for sperm selection by thermotaxis in vitro. Remarkably, the selected fraction was enriched in spermatozoa showing PTP along the whole flagellum and lower levels of DNA fragmentation when compared to the unselected fraction (38% ± 11% vs 4.4% ± 1.1% and 4.2% ± 0.4% vs 11% ± 2% respectively, t-test p < 0.003, n = 6). This procedure of in vitro capacitation of frozen/thawed stallion spermatozoa in HTF + PEN followed by in vitro sperm selection by thermotaxis represents a promising sperm preparation strategy for in vitro fertilization and intracytoplasmic sperm injection in this species.

13 June 2024 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
ILI López-González
I López-González
IOIván Oseguera-López
Iván Oseguera-López
RCR Castillo
R Castillo
ADAlberto Darszon
Alberto Darszon
In addition to its central role in cellular metabolism, adenosine 5′-triphosphate (ATP) is an important extracellular signalling molecule involved in various physiological processes. In reproduction, extracellular ATP participates in both autocrine and paracrine paths regulating gametogenesis, gamete maturation and fertilisation. This review focusses on how extracellular ATP modulates sperm physiology with emphasis on the mammalian acrosome reaction. The presence of extracellular ATP in the reproductive tract is primarily determined by the ion channels and transporters that influence its movement within the cells comprising the tract. The main targets of extracellular ATP in spermatozoa are its own transporters, particularly species-specific sperm purinergic receptors. We also discuss notable phenotypes from knock-out mouse models and human Mendelian inheritance related to ATP release mechanisms, along with immunological, proteomic, and functional observations regarding sperm purinergic receptors and their involvement in sperm signalling.